Joshua Eric Reuss, MD| Hematology and Oncology, Medical Oncology | MedStar Health
About me
Joshua Reuss, MD, is a thoracic medical oncologist at MedStar Georgetown University Hospital. He also serves as an assistant professor in the Department of Medicine at Georgetown University Medical Center.
Dr. Reuss specializes in lung cancer, mesothelioma, and thymoma. His research focuses on incorporating novel concepts and groundbreaking science to develop innovative clinical trials that advance the care of patients with lung cancer and mesothelioma. He has a particular interest in collaborating with scientific investigators to develop studies that help improve our understanding of the response and resistance mechanisms to immunotherapy in lung cancer and mesothelioma, as well as to develop trials that incorporate novel therapies that overcome immunotherapy resistance. He received the Young Investigator Award from the Conquer Cancer Foundation of the American Society of Clinical Oncology in 2019 for his research.
Dr. Reuss earned his bachelor’s degree in biology at Brandeis University and his MD from the University of Rochester School of Medicine & Dentistry. He completed his internship and residency in Internal Medicine at the University of Virginia’s Department of Medicine. He subsequently completed a fellowship in the Department of Oncology at the Johns Hopkins University School of Medicine.
MedStar Georgetown is part of the MedStar Georgetown Cancer Institute, which combines medical expertise, the latest therapies, and research across MedStar Health. Our research engine, the Georgetown Lombardi Comprehensive Cancer Center, is the only National Cancer Institute-designated comprehensive cancer center in the Washington, D.C., region. This partnership means we provide access to cutting-edge clinical trials and the latest breakthroughs in cancer care.
Clinical areas of focus
- Laparoscopy
- Lobectomy
- Lung Cancer Treatment
- Lung Metastases
- Mesothelioma
- Mesothelioma Treatment
- Pulmonary Nodule Treatment
- Pulmonary Nodules
- Pulmonary Rehabilitation
- Small Cell Lung Cancer
- Small Cell Lung Cancer Treatment
- Thoracoscopy
- Thymoma
- Thymoma Treatment
Conditions and procedures
Conditions I treat
- Abnormal Tumor Markers
- Adnexa Cancer
- Anal Cancer
- Anemia
- Aplastic Anemias And Bone Marrow Failure Syndromes
- Ascites
- B Cell Lymphoma
- Basal Cell Carcinoma Of Skin
- Benign Neoplasm Of Kidney
- Benign Neoplasm Of Skin
- Benign Neoplasm Of Urinary Organs
- Bladder Cancer
- Breast Cancer
- Bronchial Cancer
- Chest Wall Tumors
- Chronic Eosinophilic Leukemia
- Colon Cancer
- Disorders Of Carbohydrate Metabolism
- Disorders Of Mineral Metabolism
- Disorders Of White Blood Cells
- Esophagus Cancer
- Family History Of Malignant Neoplasm
- Hemorrhagic Conditions
- Intrahepatic Bile Ducts Cancer
- Larynx Cancer
- Liver Cancer
- Long Term Drug Therapy
- Lung Cancer
- Lung Metastases
- Malaise And Fatigue
- Malignant Neoplasm
- Malignant Neoplasm Of Bladder
- Malignant Neoplasm Of Cervix Uteri
- Malignant Neoplasm Of Connective And Soft Tissue
- Malignant Neoplasm Of Eye And Adnexa
- Malignant Neoplasm Of Heart
- Malignant Neoplasm Of Heart, Mediastinum And Pleura
- Malignant Neoplasm Of Lymph Nodes
- Malignant Neoplasm Of Retroperitoneum
- Malignant Neuroendocrine Tumors
- Mediastinum Cancer
- Merkel Cell Carcinoma
- Mesothelioma
- Nasopharynx Cancer
- Neoplasm Analysis
- Neuroendocrine Tumor Of The Lung
- Neutropenia
- Noninfective Gastroenteritis
- Ovarian Cancer
- Pancreas Cancer
- Papillary Carcinoma Of Breast
- Pericardium Diseases
- Plasma Cell Neoplasms
- Pleura Cancer
- Pulmonary Nodules
- Respiratory Conditions Due To External Agents
- Secondary Malignant Neoplasm Of Brain
- Small Cell Lung Cancer
- Stomach Cancer
- Subclinical Hypothyroidism
- Testicular Cancer
- Throat Cancer
- Thymoma
- Tongue Cancer
- Tonsil Cancer
- Ulcerative Colitis
- Vaginal Cancer
- Vitamin Deficiency Anemia
- Vulvar Cancer
Procedures I perform
- A1c Testing
- Adjuvant Hormone Therapy
- Antiangiogenic Therapy
- Antineoplastic Injection
- Arterial Embolization
- Arthrocentesis
- Autopsy Pathology Examination
- Bone Cancer Staging
- Bone Density Scan
- Breast Biopsy
- Bronchoscopy
- Cervical Lymph Node Dissection
- Chemotherapy Administration
- Chemotherapy Port Placement
- Chest X-Ray
- Cholecystectomy
- Cold Laser Therapy
- Computed Tomography
- Cyst Decortication
- Disease Management Education
- Ear Tube Insertion
- Endobronchial Ultrasound
- Fluid Cytology
- Fluorescence In Situ Hybridization
- Gastrointestinal Therapy
- Genetic Counseling
- Genetic Mutation Testing
- Gynecological Cancer Screening
- Hepatic Artery Infusion
- Hormone Replacement Therapy
- Imiquimod Treatment
- Immunohistochemistry Staining
- Immunotherapy
- Internal Jugular Central Line Placement
- Internal Radiation Therapy
- Intra-Arterial Infusion Of Chemotherapy
- Intraoperative Radiation Therapy
- Intravenous (IV) Fluids
- Introduction Of Antineoplastic
- Laparoscopy
- Laryngoscopy With Tumor Excision
- Laser Therapy
- Liquid Biopsy
- Liver Biopsy
- Liver Tumor Ablation
- Lobectomy
- Lung Biopsy
- Lung Cancer Screening
- Lung Cancer Treatment
- Lung Transplant
- Lymph Node Biopsy
- Magnetic Resonance Imaging (MRI)
- Mesothelioma Treatment
- Microwave Ablation
- Molecular Tumor Board
- Multidisciplinary Team Care
- Muscle Injection
- Neoadjuvant Therapy
- Non-Small Cell Lung Cancer Treatment
- Nutrition Counseling
- Pain Medication Management
- Palliative Care
- Parotid Biopsy
- Percutaneous Tumor Chemoembolization
- Pericardial Mesothelioma Treatment
- Peritoneal Mesothelioma Treatment
- Pleural Mesothelioma Treatment
- Pleurectomy
- Polymerase Chain Reaction
- Proton Beam Radiosurgery
- Pulmonary Embolization
- Pulmonary Function Tests
- Pulmonary Metastasis Treatment
- Pulmonary Nodule Treatment
- Pulmonary Rehabilitation
- Radiation Therapy
- Radiofrequency Thermoablation
- Removal Of Central Venous Access Device
- Sentinel Lymph Node Mapping
- Single Photon Emission Computed Tomography
- Small Cell Lung Cancer Treatment
- Sympathectomy
- Testicular Mesothelioma Treatment
- Thoracoscopy
- Thoracoscopy With Pleurodesis
- Thymoma Treatment
- Thymus Cancer Treatment
- Transitional Cell Carcinoma Treatment
- Transplant Critical Care Surgery
- Transplant Pneumonectomy
- Tumor Immunohistochemistry
- Tumor Marker Testing
- Wedge Resection
- Whole-Exome Sequencing
Insurance
MedStar Health accepts most major health insurance plans. If you are uncertain as to whether your individual health insurance plan is accepted at MedStar Health, please call your insurance company.
-
List of insurance plans we accept
- Aetna Managed Choice Open Access (POS)
- IH-PPO
- CIGNA PPO Plus
- TRICARE East Select
- Aetna Advantage 6350PD
- Aetna Open Choice (PPO)
- United Healthcare Choice
- Optimum Choice & Optimum Choice Preferred (POS) Cardiac Global
- Kaiser Permanente Signature - Added Choice
- M.D. IPA (HMO)
- MD IPA (HMO) & MD IPA Preferred Cardiac Global
- CareFirst (NCA) Indemnity
- TRICARE East Prime
- Cigna Preferred Medicare (HMO)
- Core Essential (HMO)
- HumanaChoice Honor's plan PPO
- Optima Family Care MCO - VA Medicaid MCO
- M.D. IPA Preferred (POS)
- CareFirst EPO
- Kaiser Permanente Signature
- Maryland Physicians Care MCO
- MedStar Family Choice - Maryland Health Choice
- Johns Hopkins Advantage MD PLUS PPO
- Fee-for-Service (FFS) District of Columbia, Maryland and Virginia Medicaid
- United Healthcare Navigate Cardiac Global
- Cigna Achieve Medicare (HMO C-SNP)
- Cigna Alliance Medicare (HMO)
- Johns Hopkins Advantage MD HMO
- Anthem Federal Employee Program Basic
- Network OA
- BCBS Out-of-State Medicare Plans (Blue Advantage)
- CareFirst MedStar Select PPO
- IH-Open EPO Plus
- Choice Care Network/HUMANA (PPO)
- United Healthcare Select HMO - EPO/NPP
- IH-POS
- Private Health Care Systems (PPO)
- CIGNA Indemnity
- Alterwood Advanatge HMO & DSNP Plans
- Aetna VA Exchange
- IH-POS Plus
- Aetna Managed Choice (POS)
- Kaiser Permanente Select - Added Choice
- Aetna Medicare Advantage HMO & PPO Plans
- Select HMO/HealthFund/Health Network
- Humana Gold Plus HMO
- OA Plus
- United Healthcare Options (PPO)
- IH-EPO Plus
- Health Services for Children with Special Needs
- Kaiser Permaenete Signature - Added Choice Cardiac Global
- Anthem BCBS Medi Blue Dual Adv
- Aetna Classic 3500
- Amerigroup DC Healthy Families
- UHC Group Medicare Advantage Plans (HMO, POS, PPO)
- Healthy Blue (HMO, POS)
- Kaiser Permanente Flexible Choice POS Cardiac Global
- Priority Partners - Maryland Health Choice
- CIGNA EPO
- Mamsi Life & Health (Indem./PPO)
- Fee-for-Service (FFS) District of Columbia, Maryland and Virginia Medicaid
- IH-Open HMO Option
- CIGNA POS/Network POS
- TriWest Healthcare Alliance
- Geisinger Medicare Advantage
- CareFirst FEP Blue Focus
- CareFirst Blue Choice Opt Out Plus Open Access (POS)
- CareFirst Blue Preferred PPO
- AmeriHealth Caritas DC Healthy Families
- Coventry of Delaware HMO/PPO
- Johns Hopkins Advantage MD PPO
- CareFirst Blue Card Program
- CIGNA HMO & Network (HMO)
- Tricare Reserve Select
- Anthem Federal Employee Program Standard
- DC/MD SHOP QHP Small Business Plans
- Choice POS II
- Aetna Quality Point of Service (POS)
- Anthem BCBS of VA HealthKeepers (HMO)
- Choice POS
- Beech Street PPO
- Medicare Direct
- Anthem BCBS of VA Key Care POS/PPO/Indemnity
- UnitedHealthcare Individual Exchange Plans
- Humana Medicare Advantage - PPO
- WellPoint Maryland - Maryland Health Choice
- United Healthcare Community Plan - VA Medicaid MCO
- Cigna True Choice Medicare (PPO)
- Aetna HMO-Open Access/Select OA/HealthFund/Health Network Option OA
- Kaiser Permanente Select
- Aetna Advantage 6350
- Amerigroup DC Alliance
- CareFirst BlueChoice HMO
- CareFirst Blue Choice Opt Out Open Access
- UnitedHealthcare Individual Exchange Plans
- UHC Passport
- Choice Fund PPO
- TRICARE for Life East
- CareFirst Maryland Point of Service Plan
- CareFirst MedStar PPO
- Mamsi Life & Health (Indem./PPO) Cardiac Global
- Aetna Better Health of VA
- POS OA
- Kaiser Permanente Select Cardiac Global
- Mamsi Life & Health (Indem./PPO)
- United Healthcare Select HMO-EPO/NPP Cardiac Global
- Cigna TotalCare (HMO D-SNP)
- United Healthcare Choice Plus Cardiac Global
- United Medicare Private Fee-for-Service (PFFS) plans
- Uniformed Services Family Health Plan
- AMERIVANTAGE/Amerigroup Community Care
- Options PPO Cardiac Global
- Navigate
- CareFirst Dual Prime HMO-SNP
- Aetna Elect Choice/ EPO (Aetna Health Fund)
- CIGNA HMO Open Access
- Magellan Complete Care of VA - VA Medicaid MCO
- Advantra Platinum (PPO)
- Aetna Advantage 5750
- CIGNA SureFit (HMO)
- United Healthcare Choice Plus
- Optimum Choice Preferred (POS)
- United Student Resources
- MedStar Family Choice - Maryland Health Choice
- Coventry Health Care National Network PPO
- HealthyBlue PPO
- CareFirst BlueCross BlueShield Advantage Core/Enhanced
- Coventry Health Care of Virginia
- CareFirst Community Health Plan of MD
- Aetna Worker's Compensation Network
- Great-West Healthcare POS/CIGNA
- Kaiser Maryland Medicaid MCO
- Medicare Advantage - Advantra Value (PPO)
- AmeriHealth Caritas DC Healthcare Alliance
- Choice POS II Open Access
- IH-Indemnity
- BlueChoice Open Access
- Aetna Premier 200PD
- Anthem BCBS of VA HealthKeepers Plus
- CIGNA PPO
- Optimum Choice
- Aetna Classic 5000
- Aetna Student Health Insurance
- MedStar Family Choice DC Healthcare Alliance
- Aetna Classic 5000PD
- Anthem BCBS of VA HealthKeepers (POS & POS OA)
- First Health PPO
- MedStar Family Choice DC Healthy Families
- NYC Medicare Advantage Plus
- Kaiser Permanente Flexible Choice 3-tier POS
- UnitedHealthcare Medicare Advantage DSNP District of Columbia
- Lasso Healthcare - Medicare Medical Savings Account
- HumanaChoice PPO
- Aetna Elect Choice/ Open Access (POS)
- IH-Open POS II
- CareFirst Administrators
- MedStar Family Choice DC Healthcare Alliance
- CIGNA Connect EPO
- UnitedHealthcare Medicare Adv. Special Needs Plans
- CareFirst Group Medicare Advantage prescription drug benefit (PPO)
- Cigna True Choice Plus Medicare (PPO)
- Jai Medical Systems - Maryland Health Choice
- HighMark
- Anthem BCBS Medi Blue Plus
- Aetna HMO
- Medicare FFS
- Blue Choice Advantage
- CareFirst Group Medicare Advantage
- Kaiser Permanente Medicare Advantage Signature and Select
- United HealthCare Community Plan - Maryland Health Choice Program
- Anthem BCBS Medi Blue SNP
- CareFirst Federal Employee Program (Std. & Basic PPO)
- United Healthcare Select Plus (POS)
- Erickson Advantage Plans
- IH-Network Only Plus
- IH-Open HMO
- IH-HMO
- Employee Health Plan
- MultiPlan, Inc
- CareFirst NASCO
- Police and Fire Clinic
- HUMANA/Choice Care Medicare Plans (Choice, Gold Choice)
- First Health PPO
- Private Fee-for-Service Plans (PFFS)
- IH-Open Network Only Plus
- OCI Direct (HMO)
- Aetna Medicare Advantage PFFS Plan
- BCBS of Michigan (BCN Advantage,Security Blue, Freedom, Medicare PLUS Blue Group PPO)
- Humana Medicare Advantage - HMO Open Access
- Aetna Better Health of MD
- Aetna Basic
- Aetna Signature Administrator PPO/TPA
- UnitedHealthcare and AARP Medicare Complete Plans
- Sentara Health
- Kaiser Permanente HMO Plus and DHMO Plus Member
- Veterans Affairs Community Care Network
- United Healthcare Choice Cardiac Global
- Aetna Traditional Choice (PPO)
- Kaiser Permanente Medicare Plus
- IH-Open POS Plus
- CareFirst Maryland Indemnity or PPO
Videos
Education
Board Certification: American Board of Internal Medicine, Medical Oncology
Fellowship: Johns Hopkins University School of Medicine (2020)
Residency: University of Virginia Medical Center (2017)
Medical School: University of Rochester (2014)
Awards
- Research Award Recipient, 3rd Annual EGFR Resisters Research Summit, 2021
- Selected Participant, Journal of Clinical Oncology – Precision Oncology Trainee Reviewer Mentoring Program, 2022
- Selected Participant, FDA-ASCO Hematology and Oncology Fellows Day Workshop, 2019
- Young Investigator Award, Conquer Cancer Foundation of ASCO, 2019
- Visiting Fellow, Investigational Drug Branch - Cancer Therapy Evaluation Program of the NCI, 2019
- Best Fellows Abstract Oral Presentation, IASLC Targeted Therapies of Lung Cancer Meeting, 2019
- Selected Participant, ASCO/AACR Methods in Clinical Cancer Research Workshop, 2018
Hospital affiliations
News and publications
i. Original Research
- Reuss JE, Brigham E, Psoter KJ, Voong KR, Shankar B, Ettinger DS, Marrone KA, Hann CL, Levy B, Feliciano JL, Brahmer JR, Feller-Kopman D, Lerner AD, Lee H, Yarmus L, Hales RK, D’Alessio F, Danoff SK, Forde PM, Suresh K, Naidoo J. Pretreatment Lung Function and Checkpoint Inhibitor Pneumonitis in NSCLC. JTO Clin Res Rep. 2021 October 01; 2(10):100220. doi: https://doi.org/10.1016/j.jtocrr.2021.100220.
- Caushi JX, Zhang J, Ji Z, Vaghasia A, Zhang B, Hsiue EH-C, Mog BJ, Hou W, Justesen S, Blosser R, Tam A, Anagnostou V, Cottrell TR, Guo H, Chan HY, Singh D, Thapa S, Dykema AG, Burman P, Choudhury B, Aparicio L, Cheung LS, Lanis M, Belcaid Z, El Asmar M, Illei PB, Wang R, Meyers J, Schuebel K, Gupta A, Skaist A, Wheelan S, Naidoo J, Marrone KA, Brock M, Ha J, Bush EL, Park BJ, Bott M, Jones DR, Reuss JE, Velculescu VE, Chaft JE, Kinzler KW, Zhou S, Vogelstein B, Taube JM, Hellmann MD, Brahmer JR, Mergoub T, Forde PM, Yegnasubramanian S, Ji H, Pardoll DM, Smith KN. Transcriptional programs of neoantigen-specific TIL in anti-PD-1-treated lung cancers. Nature. 2021;596(7870):126-132. doi: 10.1038/s41586-021-03752-4. PubMed PMID: 34608287; PubMed Central PMCID: PMC8338555.
- Reuss JE, Stern D, Foster JC, Ramaswami R, Lurain K, Chen HX, Streicher H, Kem R, Little RF, Sharon E. Assessment of cancer therapy evaluation program advocacy and inclusion rates of people living with HIV in anti-programmed death ligand 1 clinical trials. JAMA Netw Open. 2020 Dec 1;3(12):e2027110. doi: 10.1001/jamanetworkopen.2020.27110. PubMed PMID: 33258905; PubMed Central PMCID: PMC7709086.
- #Rahma OE, #Reuss JE, Giobbie-Hurder A, Razavi G-SE, Abu-Shawer O, Mehra P, Gupta S, Simon R, Khleif SN. Early 3+3 trial dose-escalation phase I clinical trial design and suitability for immune checkpoint inhibitors. Clin Cancer Res. 2020 Oct 20;clincanres.2669.2020. doi: 10.1158/1078-0432.CCR-20-2669. PubMed PMID: 33082209. #contributed equally.
- Reuss JE, Anangostou V, Cottrell TR, Smith KN, Verde F, Zahurak M, Lanis M, Murray JC, Chan HY, McCarthy C, Wang D, White JR, Yang S, Battafarano R, Broderick S, Bush E, Brock M, Ha J, Jones DR, Merghoub T, Taube J, Velculescu VE, Rosner G, Illei P, Pardoll DM, Topalian SL, Naidoo J, Levy B, Hellmann MD, Brahmer JR, Chaft JE, Forde PM. Neoadjuvant nivolumab plus ipilimumab in resectable non-small cell lung cancer. J Immunother Cancer. 2020 Sep;8(2):e001282. doi: 10.1136/jitc-2020-001282. PubMed PMID: 32929052; PubMed Central PMCID: PMC7488786.
- Naidoo J, Reuss JE, Suresh K, Feller-Kopman D, Forde PM, Steinke SM, Rock C, Johnson DB, Nishino M, Brahmer JR. Immune-related (IR)-pneumonitis during the COVID-19 pandemic: Multidisciplinary recommendations for diagnosis and management. J Immunother Cancer. 2020 Jun;8(1):e000984. doi: 10.1136/jitc-2020-000984. PubMed PMID: 32554619; PubMed Central PMCID: PMC7316105.
- Zhang J, Ji Z, Caushi JX, El Asmar M, Anagnostou V, Cottrell TR, Chan HY, Suri P, Guo H, Merghoub T, Chaft JE, Reuss JE, Tam AJ, Blosser RL, Abu-Akeel M, Sidhom JW, Zhao N, Ha JS, Jones DR, Marrone KA, Naidoo J, Gabrielson E, Taube JM, Velculescu VE, Brahmer JR, Housseau F, Hellmann MD, Forde PM, Pardoll DM, Ji H, Smith KN. Compartmental analysis of T-cell clonal dynamics as a function of pathologic response to neoadjuvant PD-1 blockade in resectable non-small cell lung cancer. Clin Cancer Res. 2020 Mar 15;26(6):1327-1337. doi: 10.1158/1078-0432.CCR-19-2931. PubMed PMID: 31754049; PubMed Central PMCID: PMC7073288.
- Anagnostou V, Niknafs N, Marrone K, Bruhm DC, White JR, Naidoo J, Hummelink K, Monkhorst K, Lalezari F, Lanis M, Rosner S, Reuss JE, Smith KN, Adleff V, Rodgers K, Belcaid Z, Rhymee L, Levy B, Feliciano J, Hann CL, Ettinger DS, Georgiades C, Verde F, Illei P, Li QK, Baras AS, Gabrielson E, Brock MV, Karchin R, Pardoll DM, Baylin SB, Brahmer JR, Scharpf RB, Forde PM, Velculescu VE. Mulitmodal genomic features predict outcome of immune checkpoint blockade in non-small-cell lung cancer. Nature Cancer. 2020 Jan 13;1:99-111. doi: 10.1038/s43018-019-0008-8. PubMed PMID: 32984843; PubMed Central PMCID: PMC7514475
- Balaji A, Zhang J, Wills B, Marrone KA, Elmariah H, Yarchoan M, Zimmerman JW, Hajjir K, Venkatraman D, Armstrong DK, Laheru DA, Mehra R, Ho WJ, Reuss JE, Heng J, Vellanki P, Donehower RC, Holdhoff M, Naidoo J. Immune-related adverse events requiring inpatient admission: spectrum of toxicity, treatment, and outcomes. J Oncol Pract. 2019 Sep;15(9):e825-e834. doi: 10.1200/JOP.18.00703. PubMed PMID: 31386608. PubMed Central PMCID: PMC6743220.
- Cavelti-Weder C, Shtessel M, Reuss JE, Jermendy A, Yamada T, Caballero F, Bonner-Weir S, Weir GC. Pancreatic duct ligation after almost complete beta-cell loss: Exocrine regeneration but no evidence of beta-cell regeneration. Endocrinology. 2013 May;154(12):4493-502. doi: 10.1210/en.2013-1463. PubMed PMID: 24029238; PubMed Central PMCID: PMC3836076.
ii. Reviews and Editorials
- Reuss JE, Gosa L, Liu SV. Antibody drug conjugates in lung cancer: State of the current therapeutic landscape and future developments. Clin Lung Ca. 2021 Jul;S1525-7304(21)00192-3. doi: 10.1016/j.cllc.2021.07.011. PubMed PMID: 34420859.
- *Reuss JE, *Forde PM. Immunotherapy for mesothelioma: rationale and new approaches. Clin Adv Hematol Oncol. 2020 Sep;18(9):562-572. PubMed PMID: 33006585.
- *Reuss JE, Suresh K, *Naidoo J. Checkpoint inhibitor pneumonitis: Mechanisms, characteristics, management strategies, and beyond. Curr Oncol Rep. 2020 May 16;22(6):56. doi: 10.1007/s11912-020-00920-z. PubMed PMID: 32415399.
- Jonna S, Reuss JE, Kim C, Liu SV. Oral chemotherapy for treatment of lung cancer. Front Oncol. 2020 Apr 28;10:793. doi: 10.3389/fonc.2020.00793. PubMed PMID: 32426292; PubMed Central PMCID: PMC7212352.
- Schenk KM, Reuss JE, Choquette K, Spira AI. A review of canakinumab and its therapeutic potential for non-small cell lung cancer. Anticancer Drugs. 2019 Oct;30(9):879-885. doi: 10.1097/CAD.0000000000000832. PubMed PMID: 31503012.
- #Rosner S, #Reuss JE, Forde PM. PD-1 Blockade in Early-Stage Lung Cancer. Annu Rev Med. 2019 Jan;70:425-35. doi: 10.1146/annurev-med-050217-025205. PubMed PMID: 30355264. #contributed equally.